COMPARATIVE EFFICACY AND SAFETY OF ROXITHROMYCIN AND CLARITHROMYCIN IN UPPER RESPIRATORY-TRACT INFECTIONS

被引：0
|
作者：
DECAMPORA, E
CAMAIONI, A
LEONARDI, M
FARDELLA, P
FIAONI, M
机构：
来源：
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 1992年 / 15卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Roxithromycin 300 mg once daily was compared with clarithromycin 250 mg b.i.d. in an open randomized trial in 200 patients with upper respiratory tract infection: sinusitis, pharyngotonsillitis, and otitis media. Average treatment duration was 9 days. Roxithromycin was more effective (p<0.01) particularly in otitis media and pharyngotonsillitis, and better tolerated (only 4% side effects, p<0.05).
引用
收藏
页码：S119 / S122
页数：4
相关论文
共 50 条
12345